Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Emmy M Dolman

Showing results (21-30 of 34) with videos related to

Pageof 4
Sort By:
Translational Oncology|March 5, 2021
High-throughput drug screening reveals Pyrvinium pamoate as effective candidate against pediatric MLL-rearranged acute myeloid leukemiaPriscilla Wander, Susan T C J M Arentsen-Peters, Sandra S Pinhanҫos, et al.
Frontiers in Oncology|March 10, 2023
MEK inhibition causes BIM stabilization and increased sensitivity to BCL-2 family member inhibitors in RAS-MAPK-mutated neuroblastomaThomas F Eleveld, Lindy Vernooij, Linda Schild, et al.
Ebiomedicine|August 27, 2020
Therapeutic vulnerabilities in the DNA damage response for the treatment of ATRX mutant neuroblastomaSally L George, Federica Lorenzi, David King, et al.
BMC Cancer|April 5, 2023
The potential of PARP as a therapeutic target across pediatric solid malignanciesKaylee M Keller, Joost Koetsier, Linda Schild, et al.
Cell Reports|August 25, 2021
Organoid-based drug screening reveals neddylation as therapeutic target for malignant rhabdoid tumorsCamilla Calandrini, Sander R van Hooff, Irene Paassen, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 4, 2021
Defects in 8-oxo-guanine repair pathway cause high frequency of C > A substitutions in neuroblastomaMarlinde L van den Boogaard, Rurika Oka, Anne Hakkert, et al.
Cancer Cytopathology|May 27, 2021
The important role of routine cytopathology in pediatric precision oncologyJinhan Xie, Amit Kumar, M Emmy M Dolman, et al.
Molecular Systems Biology|October 1, 2025
High-throughput 3D engineered paediatric tumour models for precision medicineMoonSun Jung, Valentina Poltavets, Joanna N Skhinas, et al.
Cancer Research|July 31, 2023
High-Throughput Drug Screening of Primary Tumor Cells Identifies Therapeutic Strategies for Treating Children with High-Risk CancerChelsea Mayoh, Jie Mao, Jinhan Xie, et al.
Molecular Cancer Therapeutics|March 18, 2026
Comprehensive multi-platform tyrosine kinase profiling reveals novel actionable FGFR aberrations across sarcomas affecting the youngAshleigh M Fordham, Lauren M Brown, Chelsea Mayoh, et al.
Pageof 4

Showing results (21-30 of 34) with videos related to

Sort By:
Pageof 4
Translational Oncology|March 5, 2021
High-throughput drug screening reveals Pyrvinium pamoate as effective candidate against pediatric MLL-rearranged acute myeloid leukemiaPriscilla Wander, Susan T C J M Arentsen-Peters, Sandra S Pinhanҫos, et al.
Frontiers in Oncology|March 10, 2023
MEK inhibition causes BIM stabilization and increased sensitivity to BCL-2 family member inhibitors in RAS-MAPK-mutated neuroblastomaThomas F Eleveld, Lindy Vernooij, Linda Schild, et al.
Ebiomedicine|August 27, 2020
Therapeutic vulnerabilities in the DNA damage response for the treatment of ATRX mutant neuroblastomaSally L George, Federica Lorenzi, David King, et al.
BMC Cancer|April 5, 2023
The potential of PARP as a therapeutic target across pediatric solid malignanciesKaylee M Keller, Joost Koetsier, Linda Schild, et al.
Cell Reports|August 25, 2021
Organoid-based drug screening reveals neddylation as therapeutic target for malignant rhabdoid tumorsCamilla Calandrini, Sander R van Hooff, Irene Paassen, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 4, 2021
Defects in 8-oxo-guanine repair pathway cause high frequency of C > A substitutions in neuroblastomaMarlinde L van den Boogaard, Rurika Oka, Anne Hakkert, et al.
Cancer Cytopathology|May 27, 2021
The important role of routine cytopathology in pediatric precision oncologyJinhan Xie, Amit Kumar, M Emmy M Dolman, et al.
Molecular Systems Biology|October 1, 2025
High-throughput 3D engineered paediatric tumour models for precision medicineMoonSun Jung, Valentina Poltavets, Joanna N Skhinas, et al.
Cancer Research|July 31, 2023
High-Throughput Drug Screening of Primary Tumor Cells Identifies Therapeutic Strategies for Treating Children with High-Risk CancerChelsea Mayoh, Jie Mao, Jinhan Xie, et al.
Molecular Cancer Therapeutics|March 18, 2026
Comprehensive multi-platform tyrosine kinase profiling reveals novel actionable FGFR aberrations across sarcomas affecting the youngAshleigh M Fordham, Lauren M Brown, Chelsea Mayoh, et al.
Pageof 4